2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary …
M Humbert, G Kovacs, MM Hoeper… - European heart …, 2022 - academic.oup.com
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …
clinical conditions and may be associated with a variety of cardiovascular and respiratory …
Pulmonary hypertension: a contemporary review
S Johnson, N Sommer, K Cox-Flaherty… - American journal of …, 2023 - atsjournals.org
Major advances in pulmonary arterial hypertension, pulmonary hypertension (PH)
associated with lung disease, and chronic thromboembolic PH cast new light on the …
associated with lung disease, and chronic thromboembolic PH cast new light on the …
Pulmonary arterial hypertension: diagnosis, treatment, and novel advances
The diagnosis and management of pulmonary arterial hypertension (PAH) includes several
advances, such as a broader recognition of extrapulmonary vascular organ system …
advances, such as a broader recognition of extrapulmonary vascular organ system …
Pulmonary hypertension phenotypes in patients with systemic sclerosis
A Haque, DG Kiely, G Kovacs… - European …, 2021 - Eur Respiratory Soc
Pulmonary hypertension (PH) commonly affects patients with systemic sclerosis (SSc) and is
associated with significant morbidity and increased mortality. PH is a heterogenous …
associated with significant morbidity and increased mortality. PH is a heterogenous …
Echocardiographic probability of pulmonary hypertension: a validation study
Background According to current guidelines, the diagnosis of pulmonary hypertension (PH)
relies on echocardiographic probability followed by right heart catheterisation (RHC). How …
relies on echocardiographic probability followed by right heart catheterisation (RHC). How …
Clinical characteristics and transplant-free survival across the spectrum of pulmonary vascular disease
AR Hemnes, JA Leopold, MK Radeva, GJ Beck… - Journal of the American …, 2022 - jacc.org
Abstract Background PVDOMICS (Pulmonary Vascular Disease Phenomics) is a precision
medicine initiative to characterize pulmonary vascular disease (PVD) using deep …
medicine initiative to characterize pulmonary vascular disease (PVD) using deep …
New trends in pulmonary hypertension
S Cullivan, S Gaine, O Sitbon - European Respiratory Review, 2023 - Eur Respiratory Soc
Pulmonary hypertension (PH) is a prevalent disease of the pulmonary vasculature that is
characterised by considerable morbidity and mortality. Substantial efforts have been made …
characterised by considerable morbidity and mortality. Substantial efforts have been made …
Pulmonary hypertension definition, classification, and epidemiology in Asia
JJ Anderson, EM Lau - JACC: Asia, 2022 - jacc.org
Pulmonary hypertension (PH) is caused by a range of conditions and is important to
recognize as it is associated with increased mortality. Pulmonary arterial hypertension refers …
recognize as it is associated with increased mortality. Pulmonary arterial hypertension refers …
Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study
Abstract Background and Aims Interventional studies in pulmonary arterial hypertension
completed to date have shown to be effective in symptomatic patients with significantly …
completed to date have shown to be effective in symptomatic patients with significantly …
[HTML][HTML] Echocardiography in pulmonary arterial hypertension: comprehensive evaluation and technical considerations
W Topyła-Putowska, M Tomaszewski… - Journal of Clinical …, 2021 - mdpi.com
Pulmonary arterial hypertension (PAH) is a rare, progressive disease in which there is a
persistent, abnormal increase in pulmonary artery pressure. Symptoms of pulmonary …
persistent, abnormal increase in pulmonary artery pressure. Symptoms of pulmonary …